Novo Nordisk A/S (NONOF)
124.64
+1.14
(+0.92%)
USD |
OTCM |
Apr 26, 15:25
Novo Nordisk Revenue (TTM): 28.41B for June 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 28.41B |
| March 31, 2023 | 26.38B |
| December 31, 2022 | 25.03B |
| September 30, 2022 | 24.31B |
| June 30, 2022 | 23.79B |
| March 31, 2022 | 23.24B |
| December 31, 2021 | 22.38B |
| September 30, 2021 | 21.63B |
| June 30, 2021 | 20.84B |
| March 31, 2021 | 19.92B |
| December 31, 2020 | 19.44B |
| September 30, 2020 | 19.10B |
| June 30, 2020 | 18.75B |
| March 31, 2020 | 18.84B |
| December 31, 2019 | 18.29B |
| September 30, 2019 | 18.03B |
| June 30, 2019 | 17.85B |
| March 31, 2019 | 17.72B |
| December 31, 2018 | 17.71B |
| September 30, 2018 | 17.59B |
| June 30, 2018 | 17.47B |
| March 31, 2018 | 17.31B |
| December 31, 2017 | 16.95B |
| September 30, 2017 | 16.80B |
| June 30, 2017 | 16.73B |
| Date | Value |
|---|---|
| March 31, 2017 | 16.66B |
| December 31, 2016 | 16.61B |
| September 30, 2016 | 16.56B |
| June 30, 2016 | 16.42B |
| March 31, 2016 | 16.25B |
| December 31, 2015 | 16.05B |
| September 30, 2015 | 15.94B |
| June 30, 2015 | 15.91B |
| March 31, 2015 | 15.87B |
| December 31, 2014 | 15.79B |
| September 30, 2014 | 15.62B |
| June 30, 2014 | 15.31B |
| March 31, 2014 | 15.08B |
| December 31, 2013 | 14.89B |
| September 30, 2013 | 14.57B |
| June 30, 2013 | 14.26B |
| March 31, 2013 | 13.87B |
| December 31, 2012 | 13.47B |
| September 30, 2012 | 13.10B |
| June 30, 2012 | 12.91B |
| March 31, 2012 | 12.63B |
| December 31, 2011 | 12.38B |
| September 30, 2011 | 12.04B |
| June 30, 2011 | 11.60B |
| March 31, 2011 | 11.15B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
17.85B
Minimum
Jun 2019
28.41B
Maximum
Jun 2023
21.54B
Average
20.84B
Median
Jun 2021
Revenue (TTM) Benchmarks
| Eli Lilly and Co | 34.12B |
| Amgen Inc | 28.19B |
| Pfizer Inc | 58.50B |
| AstraZeneca PLC | 45.81B |